GlassScriptPhysician profile
Henry Coker
NPI 1487159893
$692.34
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.45 · 2020: $31.91 · 2021: $14.78 · 2022: $167 · 2023: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $152.80 | 2020-2023 | |
| Novo Nordisk INC | $150.41 | 2022-2023 | Ozempic, Rybelsus |
| Lilly USA, LLC | $102.46 | 2022-2023 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $50.67 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.82 | 2022-2023 | Xifaxan |
| Alexion Pharmaceuticals, INC. | $37.61 | 2019-2020 | |
| Shield Therapeutics INC | $35.79 | 2023 | Accrufer |
| Sumitomo Pharma America, INC. | $25.93 | 2023 | Gemtesa |
| Horizon Therapeutics Plc | $21.29 | 2023 | Krystexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.60 | 2023 | Jardiance |
| Glaxosmithkline, LLC. | $18.34 | 2023 | Trelegy Ellipta |
| Exact Sciences Corporation | $14.82 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $14.80 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Coker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.